Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST (Details)

v3.21.2
NON CONTROLLING INTEREST (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Net loss attributable to the non-controlling interest     $ (1,468) $ (14,668)
BioCorRx Pharmaceuticals, Inc [Member]        
Net loss $ (2,860) $ (12,572) $ (6,067) $ (60,611)
Average Non-controlling interest percentage of profit/losses 24.2 24.2 24.2 24.2
Net loss attributable to the non-controlling interest $ (692) $ (3,042) $ (1,468) $ (14,668)